30 results
8-K
SYRS
Syros Pharmaceuticals Inc.
2 Oct 23
Cost Associated with Exit or Disposal Activities
8:49am
to the retirement of laboratory equipment. The estimate of costs that the Company expects to incur and the expected timing to complete the Restructuring … resignation.
Retirement of Nancy Simonian; Appointment of Conley Chee as President & Chief Executive Officer
On September 28, 2023, Nancy Simonian, M.D
8-K
SYRS
Syros Pharmaceuticals Inc.
15 Jun 18
Departure of Directors or Certain Officers
12:00am
retirement in 2014. From 2002 to 2003, Mr. Bonney served as Cubist’s president and chief operating officer, and from 1995 to 2001, he held various
PRE 14A
bcew3wzp 8abapa132
12 Apr 24
Preliminary proxy
4:30pm
8-K
EX-2.1
x499pcpy9adfbd9kgp7f
5 Jul 22
Syros to Raise Approximately $190 Million Through Merger with TYME Technologies and Concurrent Private Placement
7:07am
8-K
EX-1.1
mus5fa
13 Feb 20
Syros Announces $60 Million Loan Facility with Oxford Finance LLC
8:51am
8-K
EX-1.1
5d3wmu
19 Dec 23
Syros Announces Pricing of $45.0 million Underwritten Offering of Common Stock and Pre-Funded Warrants
4:59pm